Brain drain has always been a topic that worries us and makes us sweat. But the main question is, what makes young Indians knock on the doors of overseas employers? When 24-year-old entrepreneur Anagha Rajesh announced that her startup BioCompute would be moving from Bangalore to San Francisco, it was easy to view the decision as another example of Indian talent heading overseas. But Rajesh’s explanation tells a more disturbing story. This is not a lack of ambition. It’s about where breakthrough ideas find believers. After spending two years building one of India’s most ambitious deep tech ventures, Rajesh concluded that the ecosystem that got her to the starting line might not be ready to help her cross the finish line.The decision raises a larger question that India has grappled with for decades: Can the country produce world-changing science companies, or will its boldest founders continue to seek validation elsewhere?
Building the future of data storage
The challenge that Rajesh chose to tackle was never a traditional entrepreneurial idea. BioCompute is trying something that sounds like science fiction: storing digital information in DNA.As artificial intelligence, cloud computing and digital services generate unprecedented amounts of data, global storage infrastructure is facing a scale problem. Data centers consume large amounts of land, power, and cooling resources.DNA offers an entirely different possibility. Nature has been storing information efficiently for billions of years. A tiny biological structure can contain a staggering amount of data. If scientists can successfully exploit this capability, future storage systems could become smaller, denser, and more energy-efficient than today’s hardware. This vision became the foundation of BioCompute.Founded in 2024, the company is committed to enabling computing infrastructure to operate with the efficiency of biological systems. It’s an audacious goal, especially for a first-time founder in her early twenties.Yet the startup has made steady progress. Over two years, Rajesh assembled a team of professionals, raised over Rs 5 crore from investors such as WTF Fund, Grad Capital and 1517 Fund, set up lab operations, conducted thousands of experiments and built end-to-end prototypes.According to her, BioCompute became the first laboratory in India to pursue DNA data storage on such a scale. For many startups, this is a success story.For BioCompute, this is just the beginning.
Valley understands this vision
The transition from laboratory breakthroughs to commercial products is often where deep tech companies face their toughest test.Building prototypes is difficult. Building a product that customers can actually use is much harder. Rajesh believes that the next phase is where Silicon Valley offers advantages that India currently does not have.In the conversations Vyom Bhatia has on his channel around decision-making, there is a recurring theme. People in San Francisco focus less on immediate revenue and more on the resources the company needs to achieve its long-term mission.Rather than asking how quickly startups can generate revenue, they ask how they can help remove the barriers that prevent the technology from becoming a reality.This distinction is important to the founders who are developing DNA memory chips rather than other software applications. Deep tech companies often require years of research, significant capital investment and extraordinary patience to generate commercial returns.Traditional startup metrics aren’t always appropriate for companies trying to solve cutting-edge scientific problems. Rajesh has found an audience willing to think in terms of decades rather than quarters.
India’s deep tech woes
Her departure comes at an awkward time for India’s innovation ecosystem. The country has been celebrating its emergence as a startup powerhouse for years. Thousands of businesses have been created. Billions of dollars have been invested. Unicorns have become a symbol of entrepreneurial success.However, most of these successes have been in software, consumer internet, fintech and platform businesses. Deep tech remains a completely different challenge.Scientific endeavors require longer timelines, larger research budgets, and investors willing to tolerate uncertainty over the long term.Rajesh acknowledged that India has already taken steps in this direction, pointing to growing support for deep technology initiatives and research-driven funding schemes.But she’s still not convinced the ecosystem is fully ready for a product as ambitious as BioCompute. Her comment touched a sensitive nerve. Many Indian scientists, engineers and researchers working abroad often express a desire to return home. The country does not lack intelligence.Critics argue that the missing ingredient is sufficient venture capital dedicated to breakthrough technologies. If the talent exists but funding remains cautious, founders building moonshot technologies will naturally gravitate toward ecosystems where investors are more willing to support uncertainty.
Labor costs of relocation
Behind every startup relocation announcement lies a more personal story. For Rajesh, moving BioCompute to San Francisco is more than just a strategic business decision. It also means dismantling the Bengaluru operations that helped the company build it from scratch.Some of the most difficult conversations she faces involve members of her own team. They are researchers, engineers, and builders who invest countless hours experimenting, troubleshooting, and developing. Together they solve a problem in India that few others have attempted to solve.The emotional impact of these departures is evident in her reflections. Last week, she publicly listed office furniture, lab equipment and chemicals for sale, a stark visual reminder that startup transformation is about more than balance sheets and business plans. They involve people, careers, and dreams. With every move, something is left behind.
India’s future test
BioCompute’s move should not be seen simply as the story of a startup leaving India. This is a test case. If Rajesh succeeds in commercializing DNA data storage in San Francisco, her journey will become part of a larger debate about where cutting-edge innovation is most likely to flourish.For India, the lesson may be uncomfortable, but it is valuable. The country has proven that it can produce world-class talent. The next challenge is to show that it can also create an environment where the most ambitious scientific endeavors choose to stay.Because the future of competition will not depend on who has the brightest minds. It will depend on who is willing to bet on them.As BioCompute prepares to build and deliver its first DNA memory chips to customers, Rajesh is embarking on what she describes as an exciting and nerve-wracking new chapter.For her company, the destination is San Francisco. For India, the bigger question remains unanswered: Will she feel forced to leave when the next Anaga Rajesh emerges?
